Further inquiry note: Branche: Metal Goods & Engineering ISIN: DE000KC01000 WKN: KC0100 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / free trade ...
Further inquiry note: Branche: Metal Goods & Engineering ISIN: DE000KC01000 WKN: KC0100 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / free trade ...
Further inquiry note: Branche: Metal Goods & Engineering ISIN: DE000KC01000 WKN: KC0100 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / free trade ...
Ingelheim, Germany (ots/PRNewswire) - - Data From Phase II Studies Investigating BIBW 2992 (Tovok(TM)) and BIBF 1120 (Vargatef(TM)) in NSCLC Patients Presented at 13th World Conference on Lung Cancer (WCLC) INGELHEIM, Germany, August 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International ...
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
Ingelheim, Germany (ots/PRNewswire) - - For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin(R) / ...
Ingelheim, Germany (ots/PRNewswire) - - New Study Shows That Mirapexin(R)/Sifrol(R) (Pramipexole) Relieves Depressive Symptoms of Parkinson's Disease (PD), a Common Non-Motor Symptom Affecting PD Patients' Quality of Life - For Non-US Healthcare Media To view the Multimedia News Release, go to: ...
Ingelheim, Germany (ots/PRNewswire) - - Data for the Once Daily Mirapexin(R)/Sifrol(R) (Pramipexole) Formulation Under Development Show Efficacy, Safety and Tolerability Outcomes Comparable to the Current Immediate Release Formulation for the Treatment of Parkinson's Disease For non-US Healthcare Media First data ...
Ingelheim, Germany (ots/PRNewswire) - - ESO Recommends Extended Time Window for Actilyse(R) INGELHEIM, Germany, January 30 /PRNewswire/ -- - For Healthcare Media outside the U.S.A., Canada, and Japan Based on key results from the European Cooperative Acute Stroke Study (ECASS 3), the European Stroke Organisation (ESO) now recommends that Actilyse(R) (alteplase) be ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Further inquiry note: Branche: Automotive Equipment ISIN: DE0005190003 WKN: 519000 Index: DAX, CDAX, HDAX, Prime All Share Börsen: SWX Swiss Exchange / Hauptsegment Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has marked a new ...
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart attack, ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan - Favourable Safety and Efficacy Profile of Actilyse(R) Confirmed by ECASS 3 Study Investigating Treatment in an Extended Time Window up to 4.5 Hours After Symptom Onset First results from ECASS 3 (European Cooperative ...
Munich, Germany (ots/PRNewswire) - - TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care MUNICH, Germany, August 31 /PRNewswire/ -- - For non-US Healthcare Media The results of the ...
Berlin (ots/PRNewswire) - - For non-US Healthcare Media and non-UK Healthcare Media - New Studies Show Benefits of MICARDIS(R) (Telmisartan) in Combination With Amlodipine and Hydrochlorothiazide The results of two new studies of MICARDIS(R) (telmisartan) in free combination with amlodipine or fixed combination with hydrochlorothiazide (HCTZ) 25 mg confirm that a ...
Further inquiry note: Branche: Chemicals ISIN: DE0007162000 WKN: 716200 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Ingelheim, Germany (ots/PRNewswire) - - First Ever Study to Demonstrate Efficacy of Pramipexole in Treating RLS-Associated Limb Pain - For Healthcare Media Outside the U.S.A. A new study demonstrating that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce RLS-associated limb pain in patients with ...
Further inquiry note: Branche: Machine Manufacturing ISIN: DE0006052079 WKN: 605207 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade ...
Further inquiry note: Branche: Machine Manufacturing ISIN: DE0006052079 WKN: 605207 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade ...
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 (planned tradename ...
Further inquiry note: Branche: Machine Manufacturing ISIN: DE0006052079 WKN: 605207 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It ...
Further inquiry note: Branche: Chemicals ISIN: DE0007162000 WKN: 716200 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / regulated dealing Börse Hamburg / regulated dealing Börse Stuttgart / regulated ...
Ingelheim, Germany (ots/PRNewswire) - - New Data on BIBW 2992(i), a Potent, Irreversible, Second-Generation Oral Signal Transduction Inhibitor Provides Glimpse of Next Chapter in Lung Cancer Care - For Non-US Media Boehringer Ingelheim announced today from the 12th World Conference on Lung Cancer (WCLC) that the company plans to commence Phase III ...
Ingelheim, Germany (ots) - For scientific media outside the USA, Canada and Japan Boehringer Ingelheim announced today that it is undertaking a new initiative in the treatment of heart attack (ST-segment elevation myocardial infarction or STEMI). The company will sponsor a new clinical trial known as ...
